Results 151 to 160 of about 2,325 (161)

A novel multifunctional nanoparticles formed by molecular recognition between AS1411 aptamer and redox-responsive paclitaxel-nucleoside analogue prodrug for combination treatment of β-lapachone and paclitaxel

Colloids and Surfaces B: Biointerfaces, 2022
Lingbing Li
exaly  

AS1411 aptamer modified carbon dots via polyethylenimine‐assisted strategy for efficient targeted cancer cell imaging

Cell Proliferation, 2020
Tingting Kong, Liying Hao, Xiaoxiao Cai   +2 more
exaly  

Tumor targeting with a99mTc-labeled AS1411 aptamer in prostate tumor cells

Journal of Drug Targeting, 2015
Seyed Jalāl Hosseinimehr, Seyed Mohammad Abedi, Majid Piramoon   +2 more
exaly  

A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma

Investigational New Drugs, 2013
Eliezer Van Allen, Toni Choueiri, Jonathan Rosenberg   +2 more
exaly  

AS1411 aptamer-targeted Gold Nanoclusters Effect on the Enhancement of Radiation Therapy Efficacy in Breast tumor-bearing Mice

Nanomedicine, 2018
Amirhosein Kefayat, Masoud Mehrgardi, Daryoush Shahbazi-Gahrouei   +2 more
exaly  

AS1411 aptamer-decorated cisplatin-loaded poly(lactic- co -glycolic acid) Nanoparticles for Targeted Therapy of miR-21-inhibited Ovarian Cancer Cells

Nanomedicine, 2018
Jaleh Barar, Yadollah Omidi, Morteza Eskandani   +2 more
exaly  

Synthesis of AS1411-Aptamer-Conjugated CdTe Quantum Dots with High Fluorescence Strength for Probe Labeling Tumor Cells

Journal of Fluorescence, 2014
Mohammad Ramezani, Mona Alibolandi, Khalil Abnous   +2 more
exaly  

AS1411 aptamer/RGD dual functionalized theranostic chitosan-PLGA nanoparticles for brain cancer treatment and imaging

Biomaterials Advances
Rahul Pratap Singh
exaly  

Improving Chemotherapy Effectiveness: Utilizing CuS Nanoparticles Coated with AS1411 Aptamer and Chitosan for Targeted Delivery of Doxorubicin to Cancerous Cells

Journal of Pharmaceutical Sciences
Mohammad Ramezani, Mona Alibolandi, Khalil Abnous   +2 more
exaly  

Optimization of Aptamer AS1411: An Effort to Increase Binding Efficiency to Nucleolin, an Overexpressed Protein on Cancer Cells

Cancer Research Journal
exaly